Detalhe da pesquisa
1.
Nivolumab plus Gemcitabine-Cisplatin in Advanced Urothelial Carcinoma.
N Engl J Med
; 389(19): 1778-1789, 2023 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37870949
2.
Developing Folate-Conjugated miR-34a Therapeutic for Prostate Cancer: Challenges and Promises.
Int J Mol Sci
; 25(4)2024 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38396800
3.
Impact of neoadjuvant chemotherapy on survival and recurrence patterns after robot-assisted radical cystectomy for muscle-invasive bladder cancer: Results from the International Robotic Cystectomy Consortium.
Int J Urol
; 29(3): 197-205, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34923677
4.
High intratumoral CD8+ T-cell infiltration is associated with improved survival in prostate cancer patients undergoing radical prostatectomy.
Prostate
; 81(1): 20-28, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33085799
5.
Phase II study of the histone deacetylase inhibitor vorinostat (Suberoylanilide Hydroxamic Acid; SAHA) in recurrent or metastatic transitional cell carcinoma of the urothelium - an NCI-CTEP sponsored: California Cancer Consortium trial, NCI 6879.
Invest New Drugs
; 39(3): 812-820, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33409898
6.
Identification of targets for prostate cancer immunotherapy.
Prostate
; 79(5): 498-505, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30614027
7.
Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencing.
BMC Med Inform Decis Mak
; 19(1): 14, 2019 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30658646
8.
Phase 1b trial of proteasome inhibitor carfilzomib with irinotecan in lung cancer and other irinotecan-sensitive malignancies that have progressed on prior therapy (Onyx IST reference number: CAR-IST-553).
Invest New Drugs
; 35(5): 608-615, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28204981
9.
Functional reprogramming of human prostate cancer to promote local attraction of effector CD8(+) T cells.
Prostate
; 76(12): 1095-105, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27199259
10.
Adjuvant chemotherapy for stage III colon cancer: relative dose intensity and survival among veterans.
BMC Cancer
; 15: 62, 2015 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-25884851
11.
Psychological Distress, Emergency Room Utilization, and Mortality Risk Among US Adults With History of Prostate Cancer.
JCO Oncol Pract
; 20(4): 509-516, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38290084
12.
Androgen deprivation triggers a cytokine signaling switch to induce immune suppression and prostate cancer recurrence.
bioRxiv
; 2024 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38405929
13.
Developing folate-conjugated miR-34a therapeutic for prostate cancer treatment: Challenges and promises.
bioRxiv
; 2024 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38045265
14.
Phase II Trial of Concurrent Nivolumab and Radiation Therapy for Muscle-Invasive Bladder Cancer of Older or Chemotherapy-Ineligible Patients.
Int J Radiat Oncol Biol Phys
; 118(5): 1472-1480, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37981040
15.
A phase II trial of dasatinib in patients with metastatic castration-resistant prostate cancer treated previously with chemotherapy.
Anticancer Drugs
; 24(7): 743-53, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23652277
16.
Medicaid expansion and racial disparity in timely multidisciplinary treatment in muscle invasive bladder cancer.
J Natl Cancer Inst
; 115(10): 1188-1193, 2023 10 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37314971
17.
Emergence of BRCA Reversion Mutations in Patients with Metastatic Castration-resistant Prostate Cancer After Treatment with Rucaparib.
Eur Urol
; 83(3): 200-209, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36243543
18.
Integrated single-cell analysis defines the epigenetic basis of castration-resistant prostate luminal cells.
bioRxiv
; 2023 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36945493
19.
First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patients.
J Transl Med
; 10: 156, 2012 Aug 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-22862954
20.
Prostate cancer as a dedifferentiated organ: androgen receptor, cancer stem cells, and cancer stemness.
Essays Biochem
; 66(4): 291-303, 2022 09 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35866337